In breast cancer, which DDX3 has an oncogenic role, DDX3 overexpression increased cell invasion and motility by an epithelial-mesenchymal transition like change in cell morphology with decrease of E-cadherin expression [9]. The gene discussed is DDX3X; the disease is breast carcinoma.